Eli Lilly and Company (LLY) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Eli Lilly and Company's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Investment Score:
66/100
Strong
Valuation Metrics
P/E Ratio
65.65
Strong
WeakModerateStrong
P/B Ratio
48.99
Strong
WeakModerateStrong
Earnings Yield
1.52%
Weak
WeakModerateStrong
Profitability Health
Return on Equity
74.62%
Strong
WeakModerateStrong
Operating Margin
38.86%
Strong
WeakModerateStrong
Net Profit Margin
23.51%
Strong
WeakModerateStrong
Growth Indicators
Revenue Growth
32.00%
Strong
WeakModerateStrong
Net Income Growth
102.08%
Strong
WeakModerateStrong
EPS Growth
101.72%
Strong
WeakModerateStrong
Efficiency & Liquidity
Current Ratio
1.15
Moderate
WeakModerateStrong
Quick Ratio
0.89
Weak
WeakModerateStrong
Asset Turnover
0.57x
Moderate
WeakModerateStrong
Inventory Turnover
1.11x
Weak
WeakModerateStrong